MAPT and Alzheimer disease: The present study showed ECC could improve cognitive function and exert potential neuroprotective effects in experimental AD, largely through mechanisms involving antioxidant stress and antiapoptosic effects, inhibiting Aβ deposition and tau protein hyperphosphorylation, and promoting synapse protection.